Host-hepatitis C virus (HCV) interactions have both informed fundamental concepts of viral replicationand pathogenesis and provided novel insights intohost cell b
AIM To evaluate the therapeutic effects of bonemarrow-derived mesenchymal stem cells (BMSCs) with human urokinase-type plasminogen activator (uPA) onliver fibrosis,